Finance

Lists
Q2 2026 earnings • released • EPS miss -0.95% • Revenue beat +1.38%
See results
CHD:NYSE
Church & Dwight Co Inc
$98.81
+1.16%
(+1.13) 1D
Jul 31, 4:01:35 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHD...
Open
$95.71
High
$99.79
Low
$94.88
Mkt. cap
23.41B
Avg. vol.
1.97M
Volume
0.00
Dividend
1.24%
Quarterly dividend
$0.31
Ex-dividend date
Aug 14, 2026
P/E ratio
32.59
52-wk high
$106.04
52-wk low
$81.33
EPS
$3.03
Beta
0.47
Shares outstanding
236.94M
No. of employees
6K
Open
$95.71
High
$99.79
Low
$94.88
Mkt. cap
23.41B
Avg. vol.
1.97M
Volume
0.00
Dividend
1.24%
Quarterly dividend
$0.31
Ex-dividend date
Aug 14, 2026
P/E ratio
32.59
52-wk high
$106.04
52-wk low
$81.33
EPS
$3.03
Beta
0.47
Shares outstanding
236.94M
No. of employees
6K
News stories
From sources across the web
Profile
Church & Dwight Co., Inc. is an American consumer packaged goods company headquartered in Ewing Township, New Jersey. It manufactures and markets household, personal-care and specialty products in the United States and internationally. The company is best known for Arm & Hammer, whose baking soda and related products trace their origins to a business established by John Dwight and Austin Church in 1846. As of 2026, other major brands include Trojan, OxiClean, Nair, First Response, Orajel, Waterpik, Batiste, TheraBreath, Hero Cosmetics and Touchland. Church & Dwight operates through three business segments: Consumer Domestic, Consumer International and Specialty Products. Its consumer businesses sell laundry, cleaning, oral-care, hair-care, skin-care and reproductive-health products, while its specialty-products division supplies sodium bicarbonate and related materials for industrial, agricultural, medical and food applications. The company is listed on the New York Stock Exchange and is a component of the S&P 500. Wikipedia
About Church & Dwight Co Inc
CEOMatthew Farrell
Employees5.55K
Founded1846
HeadquartersEwing Township, New Jersey, New Jersey, United States
SectorHousehold goods
Analyst ratings
Based on 12 analysts giving stock ratings to CHD in the past 3 months
Buy
Buy
7
Hold
4
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for CHD in the last 3 months.
Highest
Current $98.81
$115.00 (+16.38%)
Average
$105.60 (+6.87%)
Lowest
$86.00 (-12.96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Moskow
TD Cowen
Hold
Maintained
$97.00
-1.8%
08/02/2026
Jon Andersen
William Blair
Buy
Maintained
-
-
07/31/2026
Lauren Lieberman
Barclays
Sell
Maintained
$86.00
-13%
07/31/2026
Nik Modi
RBC Capital
Buy
Maintained
$114.00
+15.4%
07/29/2026
Anna Lizzul
Bank of America Securities
Buy
Maintained
$115.00
+16.4%
07/17/2026
Peter Grom
UBS
Hold
Maintained
$104.00
+5.3%
07/16/2026
Andrea Faria Teixeira
J.P. Morgan
Hold
Maintained
$105.00
+6.3%
07/16/2026
Christopher Carey
Wells Fargo
Buy
Maintained
$110.00
+11.3%
07/08/2026
Taylor Conrad
Argus Research
Buy
Maintained
-
-
06/08/2026
Bonnie Herzog
Goldman Sachs
Buy
Maintained
$111.00
+12.3%
05/29/2026
Stephen Powers
Deutsche Bank
Buy
Maintained
$109.00
+10.3%
05/04/2026
Javier Escalante
Evercore ISI
Hold
Maintained
$105.00
+6.3%
05/04/2026
Dara Mohsenian
Morgan Stanley
Hold
Maintained
$92.90
-6%
04/23/2026
Filippo Falorni
Citi
Hold
Maintained
$100.00
+1.2%
04/15/2026
Rupesh Parikh
Oppenheimer
Buy
Maintained
$115.00
+16.4%
02/23/2026
Edward Lewis
Rothschild & Co Redburn
Hold
Upgraded
$91.00
-7.9%
02/13/2026
Last report
Jul 31, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.89 / $0.90
-0.95%miss
Revenue / Est. (USD)
1.53B / 1.51B
+1.38%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.59B
1.64B
1.47B
1.53B
Cost of goods sold
871.20M
895.80M
787.90M
-
Cost of revenue
871.20M
895.80M
787.90M
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
459.80M
443.30M
384.10M
-
Operating expense
459.80M
443.30M
384.10M
-
Total operating expenses
1.33B
1.34B
1.17B
-
Operating income
254.60M
305.10M
297.30M
-
Other non operating income
300.00K
1.80M
800.00K
-
EBT including unusual items
236.20M
188.10M
272.60M
-
EBT excluding unusual items
236.20M
285.70M
278.90M
-
Income tax expense
54.00M
44.60M
56.30M
-
Effective tax rate
22.86%
23.71%
20.65%
-
Other operating expenses
-
-
-
-
Net income
182.20M
143.50M
216.30M
-
Net profit margin
11.49%
8.73%
14.72%
13.25%
Earnings per share
0.81
0.86
0.95
0.89
Interest and investment income
2.90M
2.10M
2.50M
-
Interest expense
-23.80M
-24.60M
-24.00M
-
Net interest expenses
-20.90M
-22.50M
-21.50M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
310.70M
362.50M
353.70M
-
Gain or loss from assets sale
-
58.50M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps